Skip to main content

Advertisement

Log in

Characteristics and survival of primary vaginal malignancy: an analysis of the German nationwide cancer registry data

  • Original Article – Clinical Oncology
  • Published:
Journal of Cancer Research and Clinical Oncology Aims and scope Submit manuscript

Abstract

Background

Vaginal neoplasms are rare. To study the survival of patients depending on tumour characteristics and age, the data from the national cancer registries in Germany were analysed.

Methods

In a retrospective analysis, data from 2006 to 2015 on disease stage, survival, and factors that might affect prognosis were analysed.

Results

Altogether, out of 4004 datasets, 2194 were deemed adequate to be included in the analysis. Overall survival at 5 years (5YSR) and relative survival (5RSR) were 48.6% (95%CI 45.4–52.1%) and 58.7% (95%CI 55.3–61.2%) for carcinomas, but significantly worse at 20.2% (95%CI 8.3–32.0%) and 24.2% (95%CI 16.4–32.0%) for melanomas and 38.3% (95%CI 23.3–53.5%) and 44.4% (95%CI 31.5–56.8%) for sarcomas. 5YSR and 5RSR correlated significantly with FIGO stages (5YSR: 66.9–10.1%; 5RSR: 81.7–11.9%, = 0.04). Furthermore, survival depended on the absence of LN metastases (5RSR: 59.1% vs. 38.0%, < 0.001), and the tumour grading had an influence (5RSR: 83.7–52.1%). We also noted that prognosis was worse for older patients ≥75 years (5RSR:51.2%) than for patients <55 years (62.2%) and 55–74 years of age (61.6%).

Conclusion

Unless LN metastases, local advanced tumours and G3 grading are associated with a worse prognosis. Relative survival of older patients decreases, perhaps indicating that treatment compromises have been made

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Notes

  1. Robert Koch-Institute, Department of Epidemiology and Health Monitoring, German Centre for Cancer Registry Data, Berlin, Germany.

References

  • Adams TS, Cuello MA (2018) Cancer of the vagina. Int J Gynaecol Obstet 143(Suppl 2):14–21

    Article  PubMed  Google Scholar 

  • Alemany L, Saunier M, Tinoco L et al (2014) Large contribution of human papillomavirus in vaginal neoplastic lesions: a worldwide study in 597 samples. Eur J Cancer 50:2846–2854

    Article  CAS  PubMed  Google Scholar 

  • American Joint Committee on Cancer. Vagina. In: AJCC Cancer Staging Manual, 8th ed. New York, NY: Springer; 2017:641–47.

  • Bertoli HK, Baandrup L, Aalborg GL, Kjaer AK, Thomsen LT, Kjaer SK (2020) Time trends in the incidence and survival of vaginal squamous cell carcinoma and high-grade vaginal intraepithelial neoplasia in Denmark - a nationwide population-based study. Gynecol Oncol 158:734–739

    Article  PubMed  Google Scholar 

  • Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 68:394–424 (Erratum in: CA Cancer J Clin. 2020;70:313.)

    Article  PubMed  Google Scholar 

  • Cao D, Wu D, Xu Y (2021) Vaginal intraepithelial neoplasia in patients after total hysterectomy. Curr Probl Cancer. 45:100687

    Article  PubMed  Google Scholar 

  • Centre for Cancer Registry Data at the Robert Koch Institute: Database query with estimates of the incidence, prevalence and survival of cancer in Germany based on epidemiological state cancer registry data (DOI: https://doi.org/10.18444/5.03.01.0005.0015.0002)

  • Chyle V, Zagars GK, Wheeler JA, Wharton JT, Delclos L (1996) Definitive radiotherapy for carcinoma of the vagina: outcome and prognostic factors. Int J Radiat Oncol Biol Phys 35:891–905

    Article  CAS  PubMed  Google Scholar 

  • Daling JR, Madeleine MM, Schwartz SM et al (2002) A population-based study of squamous cell vaginal cancer: HPV and cofactors. Gynecol Oncol 84:263–270

    Article  CAS  PubMed  Google Scholar 

  • Di Donato V, Bellati F, Fischetti M, Plotti F, Perniola G, Panici PB (2012) Vaginal cancer. Crit Rev Oncol Hematol 81:286–295

    Article  PubMed  Google Scholar 

  • Diagnostics, therapy and follow-up care of vaginal cancer and its precursors. Guideline of the DGGG and OEGGG (AWMF 032/42 Oct. 2018 http://www.awmf.org/leitlinien/detail/ll/032-042.html

  • Ebisch RMF, Rutten DWE, IntHout J et al (2017) Long-lasting increased risk of human papillomavirus-related carcinomas and premalignancies after cervical intraepithelial neoplasia grade 3: a population-based cohort study. J Clin Oncol 35:2542–2550

    Article  CAS  PubMed  Google Scholar 

  • Ederer F, Astell LM, Cutler SJ (1961) The relative survival rate: a statistical methodology. Natl Cancer Inst Monogr 6:101–121

    CAS  PubMed  Google Scholar 

  • Geiss K, Meyer M (2013) A Windows application for computing standardized mortality ratios and standardized incidence ratios in cohort studies based on calculation of exact person-years at risk. Comput Methods Programs Biomed. https://doi.org/10.1016/j.cmpb.2013.05.028

    Article  PubMed  Google Scholar 

  • Gunderson CC, Nugent EK, Yunker AC et al (2013) Vaginal cancer: the experience from 2 large academic centers during a 15-year period. J Low Genit Tract Dis. 17:409–13

    Article  PubMed  Google Scholar 

  • Jentschke M, Hoffmeister V, Soergel P, Hillemanns P (2016) Clinical presentation, treatment and outcome of vaginal intraepithelial neoplasia. Arch Gynecol Obstet 293:415–419

    Article  PubMed  Google Scholar 

  • Kucera H, Vavra N (1991) Radiation management of primary carcinoma of the vagina: clinical and histopathological variables associated with survival. Gynecol Oncol 40:12–16

    Article  CAS  PubMed  Google Scholar 

  • Merino MJ (1991) Vaginal cancer: the role of infectious and environmental factors. Am J Obstet Gynecol 165:1255–1262

    Article  CAS  PubMed  Google Scholar 

  • Perez CA, Camel HM, Galakatos AE et al (1988) Definitive irradiation in carcinoma of the vagina: long-term evaluation and results. Int J Radiat Oncol Biol Phys 15:1283–1290

    Article  CAS  PubMed  Google Scholar 

  • Perez CA, Grigsby PW, Garipagaoglu M et al (1999) Factors affecting longterm outcome of irradiation in carcinoma of the vagina. Int J Radiat Oncol Biol Phys 44:37–45

    Article  CAS  PubMed  Google Scholar 

  • Puri S, Asotra S (2019) Primary vaginal malignant melanoma: a rare entity with review of literature. J Cancer Res Ther 15:1392–1394

    Article  PubMed  Google Scholar 

  • Reshko LB, Gaskins JT, Metzinger DS, Todd SL, Eldredge-Hindy HB, Silva SR (2021) The impact of brachytherapy boost and radiotherapy treatment duration on survival in patients with vaginal cancer treated with definitive chemoradiation. Brachytherapy 20:75–84

    Article  PubMed  Google Scholar 

  • Siegel RL, Miller KD, Jemal A (2019) Cancer statistics, 2019. CA Cancer J Clin 69:7–34

    Article  PubMed  Google Scholar 

  • Sopracordevole F, Barbero M, Clemente N et al (2016) High-grade vaginal intraepithelial neoplasia and risk of progression to vaginal cancer: a multicentre study of the Italian Society of Colposcopy and Cervico-Vaginal Pathology (SICPCV). Eur Rev Med Pharmacol Sci 20:818–824

    CAS  PubMed  Google Scholar 

  • Tainio K, Jakobsson M, Louvanto K et al (2016) Randomised trial on treatment of vaginal intraepithelial neoplasia-Imiquimod, laser vaporisation and expectant management. Int J Cancer 139:2353–2358

    Article  CAS  PubMed  Google Scholar 

  • United States Cancer Statistics: Data Visualizations, Centers for Disease Control and Prevention (CDC), https://gis.cdc.gov/Cancer/USCS/DataViz.html Accessed 25 April 2021

  • Urbański K, Kojs Z, Reinfuss M, Fabisiak W (1996) Primary invasive vaginal carcinoma treated with radiotherapy: analysis of prognostic factors. Gynecol Oncol 60:16–21

    Article  PubMed  Google Scholar 

  • Wu X, Matanoski G, Chen VW, Saraiya M, Coughlin SS, King JB, Tao XG et al (2008) Descriptive epidemiology of vaginal cancer incidence and survival by race, ethnicity, and age in the United States. Cancer 113:2873–82

    Article  PubMed  Google Scholar 

  • Yagi A, Ueda Y, Kakuda M et al (2017) Descriptive epidemiological study of vaginal cancer using data from the Osaka Japan population-based cancer registry: Long-term analysis from a clinical viewpoint. Medicine 96:e7751

    Article  PubMed  PubMed Central  Google Scholar 

  • Yang J, Delara R, Magrina J et al (2020) Management and outcomes of primary vaginal cancer. Gynecol Oncol 159:456–463

    Article  PubMed  Google Scholar 

Download references

Funding

Our research received no funding.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Dirk Michael Forner.

Ethics declarations

Conflict of Interest

The author report no conflict of interest.

Ethical Approval

The use of the data for this study was reviewed and approved by the Scientific Board of the German Centre for Cancer Registry Data, Robert Koch Institute.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Forner, D. Characteristics and survival of primary vaginal malignancy: an analysis of the German nationwide cancer registry data. J Cancer Res Clin Oncol 149, 1115–1122 (2023). https://doi.org/10.1007/s00432-022-03982-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00432-022-03982-7

Keywords

Navigation